These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22983911)

  • 1. Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice.
    Kusters DH; Tegtmeier J; Schurgers LJ; Reutelingsperger CP
    Mol Imaging Biol; 2012 Oct; 14(5):523-33. PubMed ID: 22983911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond
    Bucerius J; Dijkgraaf I; Mottaghy FM; Schurgers LJ
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):251-265. PubMed ID: 30302506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
    Zhao ZM; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
    Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory medicine for molecular imaging of atherosclerosis.
    Mangge H; Almer G; Stelzer I; Reininghaus E; Prassl R
    Clin Chim Acta; 2014 Nov; 437():19-24. PubMed ID: 25003647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of inflammation in atherosclerosis.
    Wildgruber M; Swirski FK; Zernecke A
    Theranostics; 2013 Nov; 3(11):865-84. PubMed ID: 24312156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive molecular imaging of vulnerable atherosclerotic plaques.
    Magnoni M; Ammirati E; Camici PG
    J Cardiol; 2015 Apr; 65(4):261-9. PubMed ID: 25702846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 10. Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque.
    Mushenkova NV; Summerhill VI; Zhang D; Romanenko EB; Grechko AV; Orekhov AN
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of contrast-enhanced intravascular ultrasound images for the assessment of coronary plaque neoangiogenesis: another step closer to the identification of the vulnerable plaque.
    Ruiz EM; Papaioannou TG; Vavuranakis M; Stefanadis C; Naghavi M; Kakadiaris IA
    Curr Pharm Des; 2012; 18(15):2207-13. PubMed ID: 22352774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating Molecular Imaging of the Vulnerable Plaque-a Vulnerable Project?
    Bala G; Broisat A; Lahoutte T; Hernot S
    Mol Imaging Biol; 2018 Jun; 20(3):337-339. PubMed ID: 29181819
    [No Abstract]   [Full Text] [Related]  

  • 13. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.
    Kowara M; Cudnoch-Jedrzejewska A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability.
    Brinjikji W; Huston J; Rabinstein AA; Kim GM; Lerman A; Lanzino G
    J Neurosurg; 2016 Jan; 124(1):27-42. PubMed ID: 26230478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging atherosclerosis and risk of plaque rupture.
    Osborn EA; Jaffer FA
    Curr Atheroscler Rep; 2013 Oct; 15(10):359. PubMed ID: 23982263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo detection of activated platelets allows characterizing rupture of atherosclerotic plaques with molecular magnetic resonance imaging in mice.
    von Elverfeldt D; von zur Muhlen C; Wiens K; Neudorfer I; Zirlik A; Meissner M; Tilly P; Charles AL; Bode C; Peter K; Fabre JE
    PLoS One; 2012; 7(9):e45008. PubMed ID: 23028736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting the vulnerable plaque in patients.
    Gonçalves I; den Ruijter H; Nahrendorf M; Pasterkamp G
    J Intern Med; 2015 Nov; 278(5):520-30. PubMed ID: 26306911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.
    MacAskill MG; Newby DE; Tavares AAS
    Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques.
    Lee SJ; Paeng JC
    Korean J Radiol; 2015; 16(5):955-66. PubMed ID: 26357491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular magnetic resonance imaging of atherosclerotic vessel wall disease.
    Nörenberg D; Ebersberger HU; Diederichs G; Hamm B; Botnar RM; Makowski MR
    Eur Radiol; 2016 Mar; 26(3):910-20. PubMed ID: 26139316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.